Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
HSA:5
Drug Approvals
Spikevax Bivalent Original/Omicron BA.4-5 (50 micrograms/50 micrograms)/mL dispersion for injection
- Approval Date
- Oct 11, 2023
HSA
Clinical Trials
No trials found
News
No news found